Replies to post #170006 on Biotech Values

[DewDiligence]

You'd have to think abbv would buy enta instead of constantly paying the high royalties, no?

I’m sure they’ve run the numbers many times. Variables that investors often overlook, such as tax rates, can greatly affect such decision-making.